GO:0051541 elastin metabolic process: Synthesis, Assembly, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051541 elastin metabolic process describes the chemical reactions and pathways involving elastin, a randomly coiled, crosslinked glycoprotein that forms elastic fibers in connective tissue.
• The process begins with tropoelastin synthesis, followed by secretion, microfibril-guided assembly, and lysyl oxidase-mediated crosslinking to form insoluble elastin.
• Elastin metabolism is essential for the elasticity of skin, lungs, and blood vessels, and its dysregulation contributes to pulmonary fibroelastosis, cardiovascular disease, and aging-related tissue dysfunction.
• Elastin degradation releases bioactive peptides such as VGVAPG, which can disrupt proteostasis and autophagy and has been linked to neurodegeneration in vitro.
• Key genes include ELN, LOX, FBLN5, MFAP2, MFAP5, and ELN-related modifiers such as EMILIN1 and LTBP2, which are studied using CRISPR knockout, knock-in, and overexpression models.
• Research methods for elastin metabolism include RNA-seq, proteomics, immunofluorescence, electron microscopy, and CRISPR library screening to identify regulators of elastic fiber assembly.
Description
Elastin metabolic process (GO:0051541) encompasses the chemical reactions and pathways involving elastin, a glycoprotein that is randomly coiled and crosslinked to form elastic fibers in connective tissue. Elastin is the dominant extracellular matrix protein responsible for tissue elasticity, allowing skin, lungs, and arteries to stretch and recoil. The process includes the synthesis of tropoelastin, its secretion, assembly onto microfibrils, and covalent crosslinking by lysyl oxidase to generate a stable, insoluble polymer. Researchers study elastin metabolic process because defects in elastin synthesis or degradation underlie a range of human pathologies, including pulmonary fibroelastosis, aortic aneurysms, and aging-related loss of tissue elasticity. Elastin turnover is extremely slow in healthy adult tissues, but during development and repair, elastogenesis is tightly regulated by transcriptional and post-translational mechanisms. In addition, elastin degradation products can act as bioactive peptides that influence cell behavior, inflammation, and neuronal function. Understanding the molecular players and regulatory steps of elastin metabolism is therefore critical for developing therapies that preserve or restore elastic fiber integrity. This article integrates the QuickGO definition with published literature to provide a research-grade overview of the genes, mechanisms, disease links, and experimental models relevant to GO:0051541.
elastin metabolic process At A Glance
| GO ID | GO:0051541 |
|---|---|
| GO term | elastin metabolic process |
| Ontology | biological_process |
| Synonym | elastin metabolism |
| Definition | The chemical reactions and pathways involving elastin, a glycoprotein which is randomly coiled and crosslinked to form elastic fibers that are found in connective tissue. |
| Major function | Synthesis, assembly, crosslinking, and turnover of elastin to provide tissue elasticity |
| Key cellular location | Extracellular matrix and secretory pathway |
| Representative genes | ELN, LOX, FBLN5, MFAP2, MFAP5, EMILIN1, LTBP2 |
| Related diseases | Pulmonary fibroelastosis, aortic aneurysm, cutis laxa, aging-related tissue dysfunction |
What Is GO:0051541?
According to the Gene Ontology, elastin metabolic process (GO:0051541) is defined as the chemical reactions and pathways involving elastin, a glycoprotein which is randomly coiled and crosslinked to form elastic fibers that are found in connective tissue. In practice, this includes the biosynthesis of tropoelastin, its post-translational modification, secretion, assembly into elastic fibers, crosslinking, and the degradation or turnover of elastin and its peptides.
Why Is elastin metabolic process Important in Cell Biology?
Elastin metabolic process is fundamental to the mechanical properties of connective tissues, and its disruption is a hallmark of several acquired and inherited diseases. Because elastin is a long-lived protein with minimal turnover in adults, defects in its synthesis or enhanced degradation can lead to irreversible loss of tissue elasticity, as seen in pulmonary fibroelastosis, vascular disease, and skin aging. Moreover, elastin-derived peptides can modulate cell signaling, autophagy, and proteostasis, with emerging implications for neurodegeneration. Studying GO:0051541 therefore provides mechanistic insight into tissue homeostasis and identifies targets for therapeutic intervention.
• Elastin is the primary determinant of elastic recoil in arteries, lungs, and skin.
• Tropoelastin synthesis and crosslinking are essential for normal development and tissue repair.
• Dysregulated elastin metabolism contributes to pulmonary fibroelastosis and interstitial lung diseases.
• Elastin degradation peptides such as VGVAPG can disrupt proteostasis and autophagy, linking elastin turnover to neurodegeneration.
• Age-related changes in extracellular matrix, including elastin, are associated with loss of tissue function.
• Elastin metabolism is a target for anti-aging skin care strategies.
• Genetic variants in ELN and related genes cause supravalvular aortic stenosis and cutis laxa.
• Elastin fibers provide structural support and regulate growth factor signaling in the matrix.
• Understanding elastin metabolism aids in tissue engineering and regenerative medicine.
• CRISPR-based models enable functional dissection of elastin metabolic genes.
What Happens During elastin metabolic process?
Tropoelastin biosynthesis and secretion
In simple terms: The cell first makes the building block of elastin, called tropoelastin, and then sends it out of the cell.
Elastin metabolic process begins with the transcription and translation of the ELN gene to produce tropoelastin, a soluble precursor protein. Tropoelastin is synthesized in the rough endoplasmic reticulum and transported through the Golgi apparatus to the cell surface, where it is secreted into the extracellular space. This step is critical because tropoelastin must remain soluble until it reaches the site of fiber assembly.
Assembly onto microfibrils
In simple terms: Tropoelastin molecules are organized onto a scaffold of microfibrils to form the early elastic fiber.
After secretion, tropoelastin molecules associate with microfibrils composed of fibrillins and microfibril-associated glycoproteins (MAGPs). This scaffold guides the alignment and orientation of tropoelastin, ensuring proper fiber morphology. Proteins such as FBLN5 and MFAP2/MFAP5 facilitate this assembly process and are essential for normal elastic fiber formation.
Crosslinking by lysyl oxidase
In simple terms: Enzymes crosslink the tropoelastin molecules together to make the elastic fiber strong and insoluble.
Lysyl oxidase (LOX) and LOX-like enzymes catalyze the oxidative deamination of lysine residues in tropoelastin, generating reactive aldehydes that spontaneously form covalent crosslinks. These crosslinks, including desmosine and isodesmosine, render elastin insoluble and highly stable. This step is essential for the mechanical integrity of elastic fibers and is a key regulatory point in elastin metabolism.
Elastin turnover and degradation
In simple terms: Old elastin can be broken down by enzymes, releasing small peptides that may have biological effects.
Elastin is degraded by elastases, including neutrophil elastase and matrix metalloproteinases (MMPs), releasing elastin-derived peptides. These peptides, such as VGVAPG, can act as signaling molecules that influence cell behavior, including autophagy and proteostasis. In aging and disease, excessive elastin degradation contributes to loss of tissue elasticity and pathological remodeling.
Regulation of elastin metabolism
In simple terms: The cell controls when and how much elastin is made and broken down.
Elastin metabolism is regulated at multiple levels, including transcriptional control of ELN by factors such as TGF-beta and IGF-1, post-transcriptional regulation by microRNAs, and extracellular proteolysis. During development, elastogenesis is high, but in adult tissues, elastin synthesis is largely downregulated, contributing to the slow turnover of elastic fibers. Dysregulation of these control mechanisms is associated with disease.
Key Genes Involved in GO:0051541 elastin metabolic process
The following genes and proteins are central to elastin metabolic process, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ELN | Encodes tropoelastin, the soluble precursor of elastin | Mutations cause supravalvular aortic stenosis and cutis laxa; target for elastogenesis studies |
| LOX | Catalyzes crosslinking of tropoelastin | Essential for insoluble elastin formation; knockout models show defective elastic fibers |
| FBLN5 | Microfibril-associated protein that facilitates elastin assembly | Mutations linked to cutis laxa; important for elastic fiber development |
| MFAP2 | Microfibril-associated glycoprotein | Regulates elastin assembly and fiber integrity |
| MFAP5 | Microfibril-associated glycoprotein | Involved in elastic fiber assembly and cell-matrix interactions |
| EMILIN1 | Elastin microfibril interface-located protein | Modulates elastin assembly and signaling |
| LTBP2 | Latent TGF-beta binding protein | Regulates TGF-beta bioavailability and elastic fiber formation |
| FBN1 | Fibrillin-1, a component of microfibrils | Provides scaffold for elastin deposition; mutations cause Marfan syndrome |
| FBN2 | Fibrillin-2 | Involved in early elastic fiber assembly |
| ELN-AS1 | Antisense RNA to ELN | Potential regulator of ELN expression |
| MMP2 | Matrix metalloproteinase-2 | Degrades elastin and other matrix components |
| MMP9 | Matrix metalloproteinase-9 | Elastin degradation in inflammation and remodeling |
| MMP12 | Macrophage elastase | Degrades elastin in lung and skin |
| CTSK | Cathepsin K | Elastolytic activity in lysosomes and extracellular space |
| TGFB1 | Transforming growth factor beta-1 | Induces elastin synthesis and regulates matrix production |
| IGF1 | Insulin-like growth factor 1 | Promotes elastin synthesis during development |
| BGN | Biglycan | Modulates elastin assembly and matrix organization |
| DCN | Decorin | Regulates collagen and elastin fibrillogenesis |
How Is elastin metabolic process Regulated?
Elastin metabolic process is regulated at transcriptional, post-transcriptional, and post-translational levels. Transcription of ELN is controlled by growth factors such as TGF-beta and IGF-1, which activate signaling cascades that promote elastin synthesis during development and repair. Post-transcriptionally, microRNAs and RNA-binding proteins can modulate ELN mRNA stability and translation. Extracellularly, lysyl oxidase activity and the availability of microfibril scaffolds regulate the efficiency of elastin crosslinking and assembly. In addition, elastin degradation by MMPs and serine proteases is tightly controlled by tissue inhibitors of metalloproteinases (TIMPs) and alpha-1 antitrypsin. Dysregulation of these regulatory mechanisms contributes to pathological elastin remodeling in diseases such as pulmonary fibroelastosis and aortic aneurysm.
elastin metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ELN | Supravalvular aortic stenosis, cutis laxa | CRISPR knockout in iPSC-derived vascular smooth muscle cells |
| LOX | Aortic aneurysm, cutis laxa | Point mutation knock-in in fibroblasts |
| FBLN5 | Cutis laxa, age-related macular degeneration | Knockout mouse or human dermal fibroblasts |
| MMP12 | Pulmonary emphysema, elastin degradation | Overexpression in lung epithelial cells |
| TGFB1 | Pulmonary fibroelastosis | Knock-in of constitutively active TGFB1 in lung fibroblasts |
Pulmonary fibroelastosis
Pulmonary fibroelastosis is characterized by excessive deposition of elastin and collagen in the lung interstitium, leading to impaired gas exchange and respiratory failure. Dysregulated elastin metabolism, including increased elastin synthesis and altered crosslinking, is a hallmark of this condition. Studies have implicated TGF-beta signaling and matrix remodeling in the pathogenesis of pulmonary fibroelastosis.
Cardiovascular disease
Elastin is a major component of large arteries, and defects in elastin metabolism cause supravalvular aortic stenosis and arterial stiffness. Mutations in ELN lead to Williams-Beuren syndrome, which includes cardiovascular abnormalities. Age-related elastin degradation contributes to arterial stiffening and hypertension.
Neurodegeneration and elastin-derived peptides
Elastin-derived peptides such as VGVAPG can disrupt proteostasis and autophagy in human neuronal cells, suggesting a potential link between elastin degradation and neurodegeneration. This emerging area highlights the importance of elastin metabolism beyond connective tissue biology.
Skin aging and cutis laxa
Loss of elastic fibers in the skin leads to wrinkles and sagging, and genetic defects in elastin metabolism cause cutis laxa, a condition characterized by loose, sagging skin. Anti-aging strategies often target elastin synthesis and protection.
From elastin metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does ELN knockout abolish elastic fiber formation? | CRISPR knockout of ELN in human dermal fibroblasts |
| How does a specific LOX point mutation affect crosslinking activity? | Point mutation knock-in in HEK293T cells |
| Can a tagged tropoelastin be used to track fiber assembly? | Knock-in of fluorescent tag at the ELN locus |
| Does overexpression of FBLN5 enhance elastin deposition? | Overexpression of FBLN5 in mesenchymal stem cells |
| Which genes regulate elastin metabolism in a genome-wide screen? | CRISPR library screening in elastin reporter cells |
| Can elastin-derived peptide VGVAPG induce autophagy defects? | Treatment of neuronal cells with synthetic peptide |
How to Study the elastin metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Expression of ELN and related genes | Transcriptional profiling of elastin metabolism |
| Western blot | Tropoelastin and LOX protein levels | Validation of gene perturbations |
| Immunofluorescence | Elastic fiber deposition and morphology | Visualization in cell and tissue models |
| Electron microscopy | Ultrastructure of elastic fibers | Assessment of fiber integrity |
| Mass spectrometry | Desmosine and elastin-derived peptides | Quantification of crosslinking and degradation |
| CRISPR library screening | Identification of regulators of elastin metabolism | Functional genomics studies |
| ELISA | Soluble elastin peptides | Biomarker measurement in disease models |
Transcriptomic analysis of elastin metabolism
RNA-seq can quantify the expression of ELN and related genes such as LOX, FBLN5, and MFAP2 in tissues or cell models. This approach helps identify transcriptional changes in elastin metabolic pathways under different conditions, including development, aging, and disease.
Proteomic and biochemical assays
Western blotting, ELISA, and mass spectrometry can measure tropoelastin, desmosine, and elastin-derived peptides. These methods provide quantitative readouts of elastin synthesis, crosslinking, and degradation.
Imaging of elastic fibers
Immunofluorescence with anti-elastin antibodies and electron microscopy can visualize elastic fiber morphology and distribution in tissues and cell cultures. These techniques are essential for assessing the impact of genetic perturbations on elastin assembly.
CRISPR screening for elastin regulators
Genome-wide CRISPR knockout or activation screens using elastin reporter cells can identify novel regulators of elastin metabolic process. Such screens have the potential to uncover therapeutic targets for diseases of elastic tissue.
How CRISPR Can Be Used to Study GO:0051541 elastin metabolic process
Knockout
CRISPR knockout of ELN, LOX, or FBLN5 can abolish or severely impair elastic fiber formation, providing causal evidence for their roles in elastin metabolic process. Knockout models are used to study the consequences of loss of function in development and disease.
Point Mutation
Point mutation knock-in can model specific human variants in ELN or LOX, such as those found in supravalvular aortic stenosis or cutis laxa. These models help dissect the functional impact of individual amino acid changes on elastin assembly and crosslinking.
Knock-in
Knock-in of tags or reporters at the ELN locus allows real-time tracking of tropoelastin synthesis, secretion, and fiber assembly. This approach is valuable for high-content imaging and screening.
Overexpression
Overexpression of elastin metabolic genes such as FBLN5 or TGFB1 can enhance elastin deposition and is used to study gain-of-function effects and potential therapeutic strategies. Overexpression models are also useful for testing anti-aging interventions.
How EDITGENE Supports elastin metabolic process Research
Researchers studying elastin metabolic process-related genes often need to determine whether a candidate gene is causally involved in elastin synthesis, assembly, or degradation. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for functional studies of GO:0051541.
Contact EDITGENE today to design your custom CRISPR model for elastin metabolic process research.
Frequently Asked Questions About elastin metabolic process
What is GO:0051541 elastin metabolic process?
GO:0051541 is a Gene Ontology biological process term defined as the chemical reactions and pathways involving elastin, a glycoprotein which is randomly coiled and crosslinked to form elastic fibers in connective tissue.
What genes are involved in elastin metabolic process?
Key genes include ELN, LOX, FBLN5, MFAP2, MFAP5, EMILIN1, LTBP2, and MMPs such as MMP2, MMP9, and MMP12.
How is elastin synthesized and assembled?
Elastin is synthesized as tropoelastin, secreted, assembled onto microfibrils, and crosslinked by lysyl oxidase to form insoluble elastic fibers.
What diseases are associated with elastin metabolism?
Diseases include pulmonary fibroelastosis, supravalvular aortic stenosis, cutis laxa, aortic aneurysm, and age-related tissue dysfunction.
What is the role of lysyl oxidase in elastin metabolism?
Lysyl oxidase catalyzes crosslinking of tropoelastin, which is essential for the stability and elasticity of mature elastin fibers.
Can elastin degradation affect neurons?
Yes, elastin-derived peptides such as VGVAPG can disrupt proteostasis and autophagy in human neuronal cells, suggesting a link to neurodegeneration.
What research methods are used to study elastin metabolism?
Methods include RNA-seq, proteomics, immunofluorescence, electron microscopy, and CRISPR screening.
How can CRISPR be used to study elastin metabolic process?
CRISPR knockout, knock-in, point mutation, and overexpression models allow functional dissection of genes involved in elastin synthesis, assembly, and degradation.
Is elastin metabolism important for skin aging?
Yes, loss of elastic fibers contributes to skin aging, and anti-aging strategies often target elastin synthesis and protection.
What is the role of TGF-beta in elastin metabolism?
TGF-beta signaling promotes elastin synthesis and regulates extracellular matrix production, and its dysregulation is linked to pulmonary fibroelastosis.
Conclusion
Elastin metabolic process (GO:0051541) is a fundamental biological process that governs the synthesis, assembly, crosslinking, and turnover of elastin, the protein responsible for tissue elasticity. Its dysregulation is implicated in a wide range of diseases, from pulmonary fibroelastosis to cardiovascular disorders and neurodegeneration. Understanding the genes and mechanisms involved provides opportunities for therapeutic intervention and tissue engineering. CRISPR-based models are powerful tools for dissecting the functional roles of elastin metabolic genes. EDITGENE offers a comprehensive suite of services to support researchers in this field, from knockout and knock-in cell lines to library screening and bioinformatics.
References
- 1. Wise SG et al.. 2009. Tropoelastin.. Int J Biochem Cell Biol 41(3):494-7 PMID: 18468477
- 2. Labat-Robert J et al.. 1990. Extracellular matrix.. FEBS Lett 268(2):386-93 PMID: 2166694
- 3. Yombo DJK et al.. 2023. Pulmonary fibroelastosis - A review.. Matrix Biol 124:1-7 PMID: 37922998
- 4. Skóra B et al.. 2025. Proteostasis and autophagy disruption by the aging-related VGVAPG hexapeptide - preliminary insights into a potential novel elastin-induced neurodegeneration pathway in an in vitro human cellular neuron model.. Neurochem Int 187:105992 PMID: 40348194
- 5. Birch HL. 2018. Extracellular Matrix and Ageing.. Subcell Biochem 90:169-190 PMID: 30779010
- 8. Rungruang R et al.. 2025. Anti-aging potential of Monascus purpureus pigments in skin care.. Pharm Biol 63(1):683-697 PMID: 40964924
